「review」の検索結果
13件：6～10件目を表示
もしかして
-
Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
r the Marketing Business of Ethical Drugs". We have appointed staff in a related department to review promotional materials and verify their compliance status.
https://www.senju.co.jp/english/about/csr03.html -
ation. February 2025 7 Desai D and Dugel PU. Complement cascade inhibition in geographic atrophy: a review. Eye. 2022;36(2):294–302. 8 Jaffe GJ, et al. C5 Inhibitor Avacincaptad Pegol for Geographic A...
https://www.senju.co.jp/index.php/system/files/content_news/2025-11/JPN_20251127.pdf -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
e of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-16. #10: 安田美穂. 観察研究(コホート研究) 久山町スタディ. あ...
https://www.senju.co.jp/rd/policy/ -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
ugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlusion (CRAO)P3（Japan） S...
http://www.senju.co.jp/english/rd/pipeline.html -
研发产品管线 | 研究与开发 | 千寿制药株式会社
T 临床试验一期以后的公开信息 药品适应症状态（地区） SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlusion (CRAO)P3（Japan） S...
http://www.senju.co.jp/chinese/rd/pipeline.html